HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

P&G Max Factor, Cover Girl North American volume up 10% in FY 1998 second quarter.

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

P&G MAX FACTOR, COVER GIRL NORTH AMERICA VOLUME UP 10% combined in the second fiscal 1998 quarter (ended Dec. 31) on a total cosmetics volume increase of 21%, Procter & Gamble Assistant Treasurer Jim Prevost told securities analysts during a Jan. 27 conference call. The Max Factor and Cover Girl volume growth excludes an increase resulting from a forward-buy strategy in December when many retailers purchased large quantities of the cosmetics brands in anticipation of increased prices in P&G's fiscal third quarter, the company said. The beauty care segment, which includes cosmetics, hair care, skin care, personal cleansing and antiperspirants/deodorants, registered a 2% volume growth during the period.

Table

View full table

Tags:
Latest Headlines

Unilever Adjusts Sustainable Plastic Goals As Industry Aspirations Meet Systemic Realities

First Generic Of B+L’s OTC Switch Lumify Approved For Dr. Reddy’s Amid Patent Infringement Battle

‘Cowboy Companies’ To Be Named, Shamed And Fined Under EU Supply Chain Directive

Beauty Firms Should Draft AI Use Policies, Even If They Don’t Plan To Use AI – Attorney

See All
UsernamePublicRestriction

Register

RS005081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By